Showing results (41-50 of 391) with videos related to

Sort By:
Pageof 40
Molecular Cancer Therapeutics|June 15, 2014
Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cellsKazuya Sugiyama, Hiroaki Kajiyama, Kiyosumi Shibata, et al.
Springerplus|September 4, 2014
Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinomaFumi Utsumi, Hiroaki Kajiyama, Kae Nakamura, et al.
Taiwanese Journal of Obstetrics & Gynecology|March 2, 2016
Efficacy and safety of daikenchuto (TJ-100) in pregnant women with constipationHiroyuki Tsuda, Tomomi Kotani, Seiji Sumigama, et al.
The Journal of Obstetrics and Gynaecology Research|February 19, 2016
Radiotherapy for persistent malignant transformation from mature cystic teratoma of the ovaryKosuke Yoshida, Hiroaki Kajiyama, Fumi Utsumi, et al.
International Journal of Clinical Oncology|February 9, 2013
Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancerHiroaki Kajiyama, Mika Mizuno, Kiyosumi Shibata, et al.
Reproductive Medicine and Biology|December 21, 2017
Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?Akira Iwase, Tomoko Nakamura, Satoko Osuka, et al.
The Journal of Obstetrics and Gynaecology Research|August 31, 2019
The usefulness of bevacizumab for relief from symptomatic malignant ascites in patients with heavily treated recurrent ovarian cancerYusuke Shimizu, Hiroaki Kajiyama, Kosuke Yoshida, et al.
International Journal of Cancer|September 26, 2007
Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinomaHiroaki Kajiyama, Kiyosumi Shibata, Mikio Terauchi, et al.
Oncology Reports|May 24, 2017
N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinomaKimihiro Nishino, Eiko Yamamoto, Kaoru Niimi, et al.
Oncology Letters|May 29, 2018
Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinomaWenting Liu, Hiroaki Kajiyama, Kiyosumi Shibata, et al.
Pageof 40